Status:

RECRUITING

Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Spondyloarthritis

Rheumatoid Arthritis

Eligibility:

All Genders

18+ years

Brief Summary

The primary objective of the study aims to compare the biodiversity of intestinal microbiota between spondylarthritis (SPA) or rheumatoid arthritis (RA) patients and healthy volunteers, by microbiota ...

Detailed Description

As secondary objectives, the study aims to analyse the relation between different clinical parameters such as age, gender, duration of the disease, or the nature of ongoing treatment, and the the comp...

Eligibility Criteria

Inclusion

  • Patients:
  • Patient ⩾ 18 years;
  • Diagnosed as spondyloarthritis (SpA) according ASAS classification, or rheumatoid polyarthritis according ACR/EULAR;
  • Affiliated to a social security scheme;
  • Have signed the written informed consent form.
  • Healthy control subjects:
  • Adult women and men;
  • Subjet free of chronic pathology;
  • Affiliated to a social security scheme;
  • Have signed the written informed consent form.

Exclusion

  • Patients:
  • Patients unable to understand the proposed study and/or sign a informed consent form;
  • Pregnant women or breast feeding women;
  • Patient ⩾ 18 years;
  • Patients under guardianship or curatorship;
  • Have taken antibiotic 1 month prior to inclusion or digestive coloscopy 6 months prior inclusion;
  • Presenting acute or chronic severe pathology may likely to interfere with the interpret of outcome;
  • Foreign patients under french AME scheme;
  • Patients had have participated in the prior study Microbiart.
  • Healthy control subjects:
  • Subjects unable to understand the proposed study and/or sign a informed consent form;
  • Pregnant women or breast feeding women;
  • Subjects \< 18 years;
  • Subjects under guardianship or curatorship;
  • Presenting acute or chronic severe pathology may likely to interfere with the interpret of outcome;
  • Refusal of subjects to participate to the study;
  • Foreign patients under french AME scheme;
  • Subjects had have participated in the prior study Microbiart.

Key Trial Info

Start Date :

November 23 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

November 1 2026

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT04292067

Start Date

November 23 2020

End Date

November 1 2026

Last Update

June 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Service de Rhumatologie, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris

Boulogne-Billancourt, France, 92100